This insight suggests a potential involvement of LPAR1 in the metastatic behavior of PDAC cells, which aligns with the previous understanding of LPAR1’s influence on pancreatic tumor progression [54, 55] and highlights its potential as a clinical and biological marker of PDAC. This evidence concerns the gene LPAR1 and pancreatic neoplasm.